Skip to content

Clinical trials

Lung Neoplasms trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Colombia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20152
20182
20191
20211
20232
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo2
Gustave Roussy, Cancer Campus, Grand Paris2
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1
Fundación GECP1
Genzyme, a Sanofi Company1
Hospital Universitario San Ignacio1
Instituto Nacional de Cancerologia, Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms18
Carcinoma, Non-Small-Cell Lung9
Adenocarcinoma of Lung2
Breast Neoplasms2
Colorectal Neoplasms2
Neoplasms2
Stomach Neoplasms2
Uterine Cervical Neoplasms2
Head and Neck Neoplasms1
Neoplasm Recurrence, Local1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.